As for safety, experts interviewed for this story said they are extremely confident in the systems set up to monitor vaccine ...

Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results , but sales fell by 1.6% year on year to $15.53 ...

While HHS Secretary Kennedy frets over food dye in Froot Loops, his 2023 attack on Gardasil — a vaccine proven to prevent ...

Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction for its HPV vaccine in China. The plaintiff told Judge Julien Xavier Neals ...

The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of $15.31 billion and $2.14, respectively.

Sales of Gardasil declined 40% due to lower demand in China, Merck maintained its sales guidance in the range of $64.1-$65.6 billion. Merck expects sales to accelerate in the second half of the year.

Let’s understand the company’s strengths and weaknesses to better analyze how to play MRK stock in the post-earnings scenario ...

Robert F. Kennedy Jr., the secretary of the Department of Health and Human Services, has long criticized HPV vaccines, particularly Gardasil, made by Merck, which is the HPV vaccine used in the U ...

1436 GMT – Merck’s struggles with Gardasil aren’t easing up. The drug maker disclosed 1Q sales of the treatment, which prevents cancers caused from the human papillomavirus, declined 41% to ...

Source: National. Cancer Institute Yes, Kennedy, who played a major part in a lawsuit against Merck over its lifesaving Gardasil vaccine, wants to get rid of ONE of the only TWO vaccines that actually ...